-
Australia's Green sold for record 252 mn rupees in IPL auction
-
Elusive December sun leaves Stockholm in the dark
-
Brendan Rodgers joins Saudi club Al Qadsiah
-
Thailand says Cambodia must announce ceasefire 'first' to stop fighting
-
M23 militia says to pull out of key DR Congo city at US's request
-
Thousands of glaciers to melt each year by mid-century: study
-
China to impose anti-dumping duties on EU pork for five years
-
Nepal starts tiger census to track recovery
-
Economic losses from natural disasters down by a third in 2025: Swiss Re
-
Indonesians reeling from flood devastation plea for global help
-
Timeline: How the Bondi Beach mass shooting unfolded
-
On the campaign trail in a tug-of-war Myanmar town
-
Bondi Beach suspect visited Philippines on Indian passport
-
Kenyan girls still afflicted by genital mutilation years after ban
-
Djokovic to warm up for Australian Open in Adelaide
-
Man bailed for fire protest on track at Hong Kong's richest horse race
-
Men's ATP tennis to apply extreme heat rule from 2026
-
Cunningham leads Pistons past Celtics, Nuggets outlast Rockets
-
10-year-old girl, Holocaust survivors among Bondi Beach dead
-
Steelers edge towards NFL playoffs as Dolphins eliminated
-
Australian PM says 'Islamic State ideology' drove Bondi Beach gunmen
-
Canada plow-maker can't clear path through Trump tariffs
-
Bank of Japan expected to hike rates to 30-year high
-
Cunningham leads Pistons past Celtics
-
Stokes tells England to 'show a bit of dog' in must-win Adelaide Test
-
EU to unveil plan to tackle housing crisis
-
EU set to scrap 2035 combustion-engine ban in car industry boost
-
Australian PM visits Bondi Beach hero in hospital
-
'Easiest scam in the world': Musicians sound alarm over AI impersonators
-
'Waiting to die': the dirty business of recycling in Vietnam
-
Asian markets retreat ahead of US jobs as tech worries weigh
-
Security beefed up for Ashes Adelaide Test after Bondi shooting
-
Famed Jerusalem stone still sells despite West Bank economic woes
-
Trump sues BBC for $10 billion over documentary speech edit
-
Chile follows Latin American neighbors in lurching right
-
Will OpenAI be the next tech giant or next Netscape?
-
Khawaja left out as Australia's Cummins, Lyon back for 3rd Ashes Test
-
Australia PM says 'Islamic State ideology' drove Bondi Beach shooters
-
Scheffler wins fourth straight PGA Tour Player of the Year
-
Tokenwell Plans to Establish U.S. Subsidiary in Dallas, Texas, to Expand its Presence in the Growing Digital Asset Hub
-
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
-
Nano One Receives C$10.9M from Financing and Government Programs
-
WelcomeVille Investment Association With Leadership From Reginald Pembroke Rolls Out a Digital Collaboration Platform
-
Grande Portage Reports Advancements of Transportation Infrastructure at the New Amalga Gold Project
-
Genflow Completes Dosing Phase of Canine Gene Therapy Trial
-
President Trump Cleaning Up Biden's Marijuana Mess - MMJ Preparing to Move FDA Huntington's Cannabis Trials Forward
-
Security beefed up for Ashes Test after Bondi shooting
-
Wembanyama blocking Knicks path in NBA Cup final
-
Amorim seeks clinical Man Utd after 'crazy' Bournemouth clash
-
Man Utd blow lead three times in 4-4 Bournemouth thriller
DataMetrex Signs LOI to Acquire Arbutus Health and Wellness Inc.
TORONTO, ON / ACCESS Newswire / April 1, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce the signing of a non-binding Letter of Intent ("LOI") to acquire Arbutus Health and Wellness Inc. ("Arbutus Health"), a multidisciplinary medical clinic in Vancouver Canada, on March 20, 2025.
Datametrex has agreed to acquire Arbutus Health for the Purchase Price of up to $1.1 million, which will be satisfied through the issuance of an aggregate of common shares in the capital of Datametrex at $0.10 per share.
Arbutus Health provides walk-in services, family medicine, skin laser treatments, and other specialty healthcare services in a single location.
The transaction is not a Non-Arm's Length Transaction, and no finder's fees will be paid. Completion of the Acquisition is subject to customary closing conditions, definitive agreements, and regulatory approvals. The Company will provide an update through a subsequent press release once a definitive agreement has been reached.
Paul Haber, CEO of Datametrex, commented, "We are pleased to take this strategic step in expanding our healthcare business. This acquisition strengthens our presence in the sector and aligns with our long-term growth strategy, allowing us on scale our operations and enhance service offerings."
Additionally, Datametrex announces that Richard Yoon has resigned from the Board of Directors, effective March 28, 2025. The Company thanks Mr. Yoon for his contributions and leadership and wishes him the best in his future endeavors. The Board will begin the process of identifying a suitable replacement in due course and further updates will be announced in the future release.
About Arbutus Health
Arbutus Health is a multidisciplinary medical clinic designed to address wait times and fragmented care in Canada's health system. Walk-in services, family doctors, skin laser treatments, and other specialties are integrated under one roof to provide timely and comprehensive care without requiring multiple referrals. Staffed by licensed healthcare professionals, patient satisfaction will be enhanced through innovative, efficient, and high-quality healthcare solutions.
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our Company website.
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
[email protected]
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
SOURCE: DataMetrex AI Ltd.
View the original press release on ACCESS Newswire
M.King--AT